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In Brief
Leong et al. reconstitute microtubule
nucleation in vitro with a minimal set of
purified fission yeast proteins—Mto1/2
[bonsai] complex, heterotetrameric
g-TuSC, and Mzt1—that assemble into a
ring-like ‘‘MGM’’ holocomplex. The small
conserved protein Mzt1 is implicated in
stabilization of Alp6, fission yeast
ortholog of mammalian g-TuSC protein
GCP3.
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Microtubule (MT) nucleation depends on the
g-tubulin complex (g-TuC), in which multiple copies
of the heterotetrameric g-tubulin small complex
(g-TuSC) associate to form a ring-like structure (in
metazoans, g-tubulin ring complex; g-TuRC) [1–7].
Additional conserved regulators of the g-TuC include
the small proteinMzt1 (MOZART1 in human; GIP1/1B
andGIP2/1A in plants) [8–13] and proteins containing
a Centrosomin Motif 1 (CM1) domain [10, 14–19].
Many insights into g-TuC regulators have come
from in vivo analysis in fission yeast Schizosaccharo-
myces pombe. The S. pombe CM1 protein Mto1
recruits the g-TuC to microtubule-organizing centers
(MTOCs) [14, 20–22], and analysis of Mto1[bonsai], a
truncated version of Mto1 that cannot localize to
MTOCs, has shown that Mto1 also has a role in
g-TuC activation [23]. S. pombe Mzt1 interacts with
g-TuSC and is essential for g-TuC function and local-
ization to MTOCs [11, 12]. However, the mechanisms
by which Mzt1 functions remain unclear. Here we
describe reconstitution of MT nucleation using puri-
fied recombinant Mto1[bonsai], the Mto1 partner
protein Mto2, g-TuSC, and Mzt1. Multiple copies of
the six proteins involved coassemble to form a
34-40S ring-like ‘‘MGM’’ holocomplex that is a potent
MT nucleator in vitro. Using purified MGM and sub-
complexes, we investigate the role of Mzt1 in MT
nucleation. Our results suggest that Mzt1 is critical
to stabilize Alp6, the S. pombe homolog of human
g-TuSC protein GCP3, in an ‘‘interaction-competent’’
form within the g-TuSC. This is essential for MGM to
become a functional nucleator.
RESULTS AND DISCUSSION
Mzt1 Prevents Large-Scale Aggregation of the Fission
Yeast g-TuSC In Vitro
S. pombe g-TuSC contains the proteins g-tubulin, Alp4 (homo-
log of human GCP2; see Figure S1A for protein nomenclature),Current Biology 29, 2199–2207
This is an open access article undand Alp6 (homolog of human GCP3) in a 2:1:1 ratio [24]. We pu-
rified g-TuSC using proteins expressed in insect cells and an
MBP affinity tag on Alp6 (Figure 1A). After density-gradient
centrifugation, g-TuSCAlp6-MBP was present mainly in the pellet
fraction, with a sedimentation coefficient of at least 150S, indi-
cating large, non-physiological aggregates (Figures 1C and
S1C). Consistent with this, in size-exclusion chromatography
(SEC) on Superose 6, some g-TuSCAlp6-MBP was not recovered
from the column, and the remainder eluted mainly in the void
volume (Figure 1B).
Next, we coexpressed g-TuSCAlp6-MBP proteins with Mzt1.
Mzt1 is conserved in animals, plants, and many fungi, although
not in the group of Saccharomycotina that includes budding
yeast S. cerevisiae [10]. In S. pombe, Mzt1 is an essential
component of the g-TuC and interacts with Alp6 [11, 12]. Mzt1
copurified with g-TuSCAlp6-MBP, as a g-TuSCAlp6-MBP:Mzt1 com-
plex (Figures 1D and S1B). Interestingly, upon density-gradient
centrifugation, relatively little g-TuSCAlp6-MBP:Mzt1 complex
was pelleted; instead, the complex showed a sedimentation
peak at 24S, with a broad overall sedimentation profile relative
to S-value standards (Figures 1F, S1D, and S2A). Because
g-TuSCs from S. cerevisiae and Drosophila typically sediment
at 10–12S [25–27], this suggests that under our experimental
conditions, g-TuSCAlp6-MBP:Mzt1 may coexist in several lower-
order oligomerization states.
In SEC on Superose 6, although some g-TuSCAlp6-MBP:Mzt1
was not recovered from the column, most of the g-TuSCAlp6-MBP:
Mzt1 that did elute from the column eluted at a position expected
for g-TuSCs, and a much smaller proportion eluted in the void
volume (Figure 1E).
We conclude that Mzt1 binds stably to g-TuSC and prevents
its aggregation in vitro. The presence of TuSC:Mzt1 oligomers
on density gradients raises the possibility that Mzt1 may also
contribute to g-TuSC-g-TuSC interactions. However, because
g-TuSC aggregates in the absence of Mzt1, it is equally
possible that the effect of Mzt1 on g-TuSC oligomerization is
indirect.
Mto1/2[bonsai] Complex Interacts with g-TuSC:Mzt1 to
Form an ‘‘MGM’’ Holocomplex
Mto1[bonsai] lacks N- and C-terminal residues (1–130 and 550–
1,115, respectively) that targetMto1 toMTOCs [21, 22]. However,
Mto1[bonsai] still interacts with the Mto1 partner protein Mto2 to
generate an Mto1/2[bonsai] complex [23]. In vivo, Mto1/2[bonsai], July 8, 2019 ª 2019 The Authors. Published by Elsevier Ltd. 2199
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. Mzt1 Prevents Large-Scale Ag-
gregation of the g-TuSC In Vitro
(A) SDS-PAGE of g-TuSCAlp6-MBP (without Mzt1),
purified on amylose via Alp6-MBP.
(B) Superose 6 size-exclusion chromatography
(SEC) of g-TuSCAlp6-MBP, with corresponding
SDS-PAGE of indicated fractions. The majority of
eluting g-TuSCAlp6-MBP elutes in the void volume.
(C) SDS-PAGE of 80-min density-gradient centri-
fugation of g-TuSCAlp6-MBP (SYPRO Ruby stain).
Most g-TuSC is in the pellet. Results from a 45-min
centrifugation are shown in Figure S1C.
(D) SDS-PAGE of g-TuSCAlp6-MBP with Mzt1
(g-TuSCAlp6-MBP:Mzt1), purified as above. Mzt1 is
shown from a higher-contrast image, shown in
Figure S1B.
(E) Superose 6 SEC of (g-TuSCAlp6-MBP:Mzt1), with
corresponding SDS-PAGE of indicated fractions.
Alp6-MBP, Alp4, g-tubulin (Gtb1), and Mzt1 coe-
lute, much later than the void volume.
(F) SDS-PAGE of 80-min density-gradient centri-
fugation of g-TuSCAlp6-MBP:Mzt1 (SYPRO Ruby
stain). g-TuSCAlp6-MBP:Mzt1 sediments with a
broad profile centered at 24S. Mzt1 was visual-
ized on a separate gel with higher acrylamide
concentration. Results from a 45-min centrifuga-
tion are shown in Figure S1D.
See also Figure S1.forms puncta that contain g-TuSCs and nucleate single MTs [23].
To determine if Mto1/2[bonsai] interacts directly with g-TuSC
in vitro, we purified the Mto1/2[bonsai] complex from insect-cell
expression and combined it with g-TuSCAlp6-MBP:Mzt1. Upon
density-gradient centrifugation, Mto1/2[bonsai] alone sedi-
mented with a peak at 10S and a long ‘‘tail’’ at higher S-values,
suggesting multiple oligomerization states (Figures 2A and S2A).
Combining Mto1/2[bonsai] with g-TuSCAlp6-MBP:Mzt1 led to the
formation of a new holocomplex, in which all components of
both complexes cosedimented, with a new peak at 34–40S (Fig-
ures 2B, S2A, and S2D). Like the individual complexes, the
holocomplex had a broad sedimentation profile relative to S-value
standards (Figure S2A); we speculate that this could be due
to conformational heterogeneity and/or small variations in
protein copy number within the holocomplex. We will refer to
the Mto1/2[bonsai]:g-TuSC:Mzt1 holocomplex as the ‘‘MGM’’
(Mto/Gamma/Mozart) holocomplex. We also generated the
MGM holocomplex via coexpression of Mto1/2[bonsai] with
g-TuSCAlp6-MBP:Mzt1 (Figure S2B). MGM purified from coexpres-2200 Current Biology 29, 2199–2207, July 8, 2019sion, which had essentially the same
compositionandsedimentationproperties
as MGM obtained by combining separate
complexes (Figures S2C and S2E), was
used in subsequent experiments.
We investigated protein-protein con-
tacts within the MGM holocomplex by
chemical crosslinking mass spectrom-
etry (CLMS), using the zero-length
crosslinker 1-ethyl-3-(3-dimethylamino-
propyl)carbodiimide (EDC) (Figure 2C).
Although this analysis was not exhaus-
tive, we observed crosslinks betweenAlp4 and Alp6 along the length of these two proteins, consis-
tent with their general parallel lateral alignment in current
models for g-TuC organization [1]. In addition, we observed
specific crosslinks from both Alp4 and Alp6 to the Mto1
[bonsai] CM1 domain and/or its immediate flanking regions.
Interestingly, crosslinks from Alp4 and Alp6 N-terminal regions
tended to be to the C-terminal portion of the CM1 domain,
while crosslinks from Alp4 and Alp6 C-terminal regions tended
to be to the N-terminal portion of the CM1 domain. This raises
the possibility that the CM1 domain, which is adjacent to
coiled-coil regions, may be oriented antiparallel to Alp4 and
Alp6.
Imaging of the MGM holocomplex by negative-stain electron
microscopy revealed a range of ring- and crescent-like struc-
tures with a diameter of 25 nm, reminiscent of isolated meta-
zoan g-TuRC (Figures 2D and S2F [28, 29]). These features
suggest that MGM may have an overall structure similar to
g-TuRC; further workmay be required to optimizemorphological
preservation.
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Figure 2. g-TuSC:Mzt1 Interacts with Mto1/
2[bonsai] Complex to Form An ‘‘MGM’’
(Mto/Gamma/Mzt) Holocomplex
(A) SDS-PAGE of 80-min density-gradient centri-
fugation of Mto1/2[bonsai].
(B) SDS-PAGE of 80-min density-gradient centri-
fugation of Mto1/2[bonsai] mixed (after purifica-
tion) with g-TuSCAlp6-MBP:Mzt1. Mixing alters the
sedimentation profiles of both complexes, and all
constituent proteins cosediment. Mzt1 was visu-
alized on a separate gel with higher acrylamide
concentration. Gels are stained with SYPRO
Ruby. Representative sedimentation profiles from
(A) and (B) are shown in Figure S2A.
(C) Interactions between different proteins within
MGM holocomplex, identified by zero-length
chemical crosslinking and mass spectrometry
(see STAR Methods). For simplicity, only inter-
protein crosslinks are shown. In this experiment,
crosslinks to Mzt1 (a very small protein with few
useful proteolytic fragments) were not identified.
(D) Negative-stain electron microscopy of MGM.
The image is a portion of a field shown in
Figure S2F. In (C) and (D), MGM was purified
from coexpression of Mto1/2[bonsai] and
g-TuSCAlp6-MBP:Mzt1 proteins.
See also Figures 1 and S2.The MGM Holocomplex Is a Potent Microtubule
Nucleator In Vitro
To determine if the MGM holocomplex is sufficient for MT
nucleation in vitro, we tested its ability to promote polymeriza-
tion of porcine brain tubulin at tubulin concentrations below
the critical concentration for spontaneous assembly, without
any further additives to promote MT assembly. We first as-
sayed polymerization by measuring fluorescence of 4’,6-dia-
midino-2-phenylindole (DAPI) bound to MT polymer [30]. At
a concentration of 4.5 mg/mL (estimated to be 1.3 nM;
see STAR Methods), MGM holocomplex promoted tubulin
polymerization to a level comparable to that obtained by incu-
bating tubulin with paclitaxel, although the rate of paclitaxel-
induced polymerization was somewhat faster (Figures 3A
and S3B). At a 10-fold lower concentration (i.e., estimated
130 pM), MGM promoted polymerization more slowly and
to a lesser extent (Figure 3A); this indicates that MGM-induced
polymerization is dose dependent. Assays of subcomplexes
lacking specific components of the MGM holocomplex
showed that the full complement of MGM proteins is required
for activity (Figures 3A and S3C).
To confirm that increased DAPI fluorescence represented
bona fide MTs, we assayed MGM holocomplex activity using
rhodamine-tubulin and fluorescence microscopy (Figures 3B,
3C, and S3D). MGM promoted the formation of morphologically
normal MTs, while subcomplexes did not promote polymeriza-
tion significantly beyond that seen with tubulin alone.
Because MGM used in MT nucleation experiments contained
MBP-tagged Alp6, and CLMS experiments suggested that the
MBP moiety is spatially close to g-tubulin (Figure 2C), we
confirmed that MBP was not artifactually promoting MGM func-
tion. After TEV cleavage and removal of MBP, MGM remained
active in polymerization assays (Figures S3E–S3I). We conclude
that the MGM holocomplex is an MT nucleator in vitro.Relative to recently reconstituted MT nucleation complexes us-
ingS.cerevisiaeandC.albicansproteins [10, 31],MGMappears to
beapotent nucleator. TheS. cerevisiaecomplex (i.e.,g-TuSCplus
anN-terminal fragmentof theCM1proteinSpc110) showsastrong
preference for S. cerevisiae tubulin and is only weakly active on
mammalian tubulin, and nucleation assays for this complex
included glycerol to aid MT assembly [31]. Nucleation assays for
theC. albicans complex (i.e.,Cag-TuSC,CaMzt1, and anN-termi-
nal fragment of either of the CM1 proteinsCaSpc110 orCaSpc72)
usedporcinebrain tubulin but also includedglycerol, aswell as low
concentrations of paclitaxel, supposedly to counteract species-
specific differences between Cag-TuSC and mammalian tubulin
[10]. In addition, the C. albicans complex was used at relatively
high concentrations (80 nM, based on the same estimation pro-
cedure that we applied to MGM). Although different assay condi-
tions make detailed comparisons difficult, one possible reason
that MGMmay be a particularly good nucleator is that in addition
to Mto1[bonsai], it also contains Mto2. Mto2 appears to promote
Mto1 multimerization in vivo [23], and Mto2 could also potentially
serve to orient Mto1 CM1 domains relative to g-TuSCs.
MT nucleation in vitro by a ring-like 34-40SMGMholocomplex
is consistent with our previous characterization of single-MT
nucleation in vivo by puncta that contain Mto1/2[bonsai] and
g-TuSC in copy numbers similar to that in g-TuRC [23]. Reconsti-
tution of nucleation using only Mto1/2[bonsai], g-TuSC, and
Mzt1 also extends previous findings that S. pombe homologs
of human GCP4, GCP5 and GCP6 (Gfh1, Mod21, and Alp16,
respectively) are not essential for nucleation, although they do
contribute to overall MT polymerization in vivo [32, 33].
Mzt1 Stabilizes Alp6 in an ‘‘Interaction-Competent’’
State within Higher-Order Complexes
We next investigated the role of Mzt1 within the MGM holo-
complex. By comparing different tag-based purifications ofCurrent Biology 29, 2199–2207, July 8, 2019 2201
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Figure 3. The MGM Holocomplex Is a Potent Microtubule Nucleator
In Vitro
(A) DAPI fluorescence assay for microtubule (MT) polymerization, using
porcine brain tubulin and the indicated complexes and concentrations. The
MGM holocomplex nucleates MTs in a dose-dependent manner. The esti-
mated molarity of MGM is based on assumption that Mto1/2[bonsai] and
g-TuSCAlp6-MBP:Mzt1 coassemble into a structure similar to the mammalian
2202 Current Biology 29, 2199–2207, July 8, 2019coexpressed MGM proteins in the absence versus presence of
Mzt1, we found thatMzt1 is required for Alp6 andMto1/2[bonsai]
to be mutually compatible within a larger holocomplex (Figures
4A–4D and S4A–S4E). In MBP purifications from cells co-ex-
pressing g-TuSCAlp6-MBP and Mto1/2[bonsai], relative levels of
copurifying Mto1[bonsai] were 75% decreased in the absence
versus the presence of Mzt1 (Figures 4A, 4B, and S4A). Similarly,
in GST and Strep-tag purifications from cells expressing un-
tagged g-TuSC and either Mto1/2[bonsai]GST-Mto1[bonsai] or
Mto1/2[bonsai]Strep-Mto1[bonsai], levels of copurifying Alp6 were
more than 60%–70%decreased in the absence versus the pres-
ence of Mzt1, compared to levels of other proteins (Figures 4C,
4D, and S4B–S4E).
These results suggested that Mzt1 has a specific role in stabi-
lizing Alp6 within the MGM holocomplex, i.e., upon Mto1/2
[bonsai] binding to g-TuSCs. Consistent with this, we found
that Mzt1 copurified with Alp6-MBP but not with Alp4-MBP (Fig-
ure 4E), confirming previous yeast two-hybrid analysis [11].
CLMS analysis of purified Alp6-MBP:Mzt1 complexes further
confirmed that Mzt1 interacts with an N-terminal region of Alp6
(Figure S4F) [11]. These results are consistent with observations
for the equivalent proteins in C. albicans [10], although they may
differ from the overall picture suggested for metazoan cells (see
‘‘Concluding Remarks’’).
We considered two possibilities for how Mzt1 could
contribute to stability of Alp6 within the MGM holocomplex.
The first possibility was that Mzt1 could bind to both Alp6
and Mto1[bonsai], as a ‘‘bridge,’’ as recently described for ho-
mologs of these proteins in C. albicans [10]. However, Mzt1 did
not copurify with GST-tagged Mto1/2[bonsai] unless g-TuSC
was also present (Figure 4F). This suggests that Mzt1 does
not bind strongly to Mto1/2[bonsai] on its own, although we
cannot rule out that they interact very weakly, or possibly
only cooperatively, together with g-TuSC. Consistent with this
result, the amount of Mzt1 copurifying with g-TuSCAlp6-MBP
was not altered by the presence versus absence of Mto1/2
[bonsai] (Figure S4G).
The second possibility, motivated in part by the aberrant ag-
gregation of g-TuSC when Mzt1 is absent (Figures 1 and S1),
was that Mzt1 may support Alp6 stability within the MGM holo-
complex more indirectly—for example, by promoting the correct
folding or conformation of Alp6. We therefore tested how Mzt1
affects the properties of purified Alp6-MBP alone in vitro. In the
absence of Mzt1, Alp6-MBP eluted in the void volume during
SEC on a Superose 6 column, suggesting that it was forming
non-physiological aggregates; by contrast, in the presence of
Mzt1, Alp6-MBP co-eluted with Mzt1 as a well-defined species
(Figure 4G). This suggests that Mzt1 contributes to folding of a
subregion of Alp6 (i.e., the Alp6 N terminus) and/or protects a
surface of Alp6 that would otherwise promote aggregation.g-TuRC (see STAR Methods). Additional controls are shown in Figures
S3A–S3C.
(B) Rhodamine-tubulin fluorescence microscopy assay for MT polymerization.
(C) Quantification of MT polymerization for experiments in (B). Each data point
represents total MT fluorescence within a randomly chosen field. Inset shows
expanded scale for non-MGM samples. Quantification of MT number per field
is shown in Figure S3D. Scale bar, 10 mm.
See also Figure S3.
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Figure 4. Mzt1 Stabilizes Alp6 in an ‘‘Interaction-Competent’’ State within Higher-Order Complexes
(A) SDS-PAGE of amylose (MBP) purification of coexpressed g-TuSCAlp6-MBP and Mto1/2[bonsai] in the absence versus presence of Mzt1. Mzt is required for
efficient copurification of Mto1[bonsai] with g-TuSC. Note that the total yield of g-TuSC proteins is also decreased. Western blots of protein inputs are shown in
Figure S4A.
(B) Quantification of copurification of the indicated proteins from (A). Values for copurification are expressed as ratios, to correct for differences in yield, and
normalized to values obtained in the presence of Mzt1.
(C) SDS-PAGE and anti-Mzt1 immunoblot of glutathione-agarose (GST) purification of coexpressed Mto1/2[bonsai]GST-Mto1[bonsai] and g-TuSC in the absence
versus presence of Mzt1. Mzt is required for efficient copurification of Alp6 with Mto1/2[bonsai]. Anti-Alp6 western blot indicates comparable Alp6 input levels in
absence versus presence of Mzt1.
(D) Quantification of copurification of the indicated proteins in (C). Quantification was based on western blots shown in Figure S4B. Equivalent experiments using
Mto1/2[bonsai]Strep-Mto1[bonsai] are shown in Figures S4C–S4E.
(E) SDS-PAGE of amylose (MBP) purification of Alp4-MBP or Alp6-MBP coexpressed with Mzt1. Mzt1 copurifies with Alp6-MBP but not with Alp4-MBP.
Anti-Mzt1 western blot indicates comparable Mzt1 levels in the two inputs.
(F) SDS-PAGE and anti-Mzt1 western blot of glutathione-agarose purification of coexpressed Mto1/2[bonsai]GST-Mto1[bonsai] and Mzt1 in the absence versus
presence of g-TuSC. Mzt1 does not copurify with Mto1/2[bonsai] unless g-TuSC is also present. The graph shows quantification of anti-Mzt1 western blot,
normalized to value in first lane.
(G) Superose 6 size-exclusion chromatography of Alp6-MBP purified alone (blue) or from coexpression with Mzt1 (red). Alp6-MBP elutes in void volume, while
Alp6-MBP:Mzt1 elutes much later. Inset shows SDS-PAGE of indicated fractions for Alp6-MBP:Mzt1.
(H) SDS-PAGE of amylose (MBP) purification of coexpressed Alp4-MBP and Mto1/2[bonsai] in the absence versus presence of Mzt1. Mto1/2[bonsai] copurifies
with Alp4-MBP, independent of Mzt1 and other g-TuSC proteins. The control experiment for non-specific binding of Mto1/2[bonsai] to amylose is shown in
Figure S4H.
See also Figure S4.Bringing together our finding that both Alp4 and Alp6 crosslink
directly with the Mto1[bonsai] CM1 region (Figure 2C) with our
finding that Mzt1 is required specifically to stabilize Alp6 (but
not Alp4) within the MGM holocomplex (Figures 4C, 4D, and
S4B–S4E), we predicted that Alp4 alone should be able to
interact with Mto1/2[bonsai]. Consistent with this, we found
that Mto1/2[bonsai] copurified with Alp4-MBP, independent of
Alp6, Mzt1, and g-tubulin (Figures 4H and S4H).Overall, our results indicate that S. pombe Mzt1 maintains
Alp6, the homolog of human GCP3, in an ‘‘interaction-compe-
tent’’ state that prevents large-scale aggregation of g-TuSCs
and allows Mto1/2[bonsai] to bind to g-TuSC without disrupt-
ing g-TuSC integrity. This is of particular interest in relation
to models motivated by cryo-EM structural analysis of
S. cerevisiae g-TuC, which suggests that Spc98 (Alp6/GCP3
homolog) must undergo a conformational change in orderCurrent Biology 29, 2199–2207, July 8, 2019 2203
for g-TuSCs within a potential MT-nucleating complex to form
an active nucleator [18, 31, 34] Specifically, rotation of the
Spc98 C-terminal half about a central hinge region is thought
to allow g-tubulin molecules from all g-TuSCs to match the
cross-sectional geometry of the MT. Multiple lines of evidence
have suggested that CM1 proteins play a critical role in this
activation step [10, 17, 18, 23, 35]. In this context, we specu-
late that in the absence of Mzt1, conformational changes in
g-TuSC induced by Mto1/2[bonsai] binding may lead to Alp6
instability within g-TuSCs. Conversely, in the presence of
Mzt1, Alp6 may be able to tolerate Mto1/2[bonsai]-driven
conformational changes without a decrease in affinity for its
interactors. Future structural analysis of g-TuSCs in different
states will help to illuminate these issues.
To complement our in vitro experiments, we investigated
how loss of Mzt1 in vivo affects g-TuSC and its interaction
with Mto1/2[bonsai]. We constructed a 3xFLAG-mzt1 allele un-
der control of the thiamine-repressible nmt81 promoter. In the
absence of thiamine, wild-type cells and nmt81:3xFLAG-mzt1
cells grew equally well (Figure S4I), although further experi-
ments suggested that 3xFLAG-Mzt1 was not fully functional
relative to wild-type untagged Mzt1 (Figure S4J). In the pres-
ence of thiamine, while wild-type cells grew normally,
nmt81:3xFLAG-mzt1 cells showed almost no growth (Fig-
ure S4I). Interestingly, under these repressing conditions,
nmt81:3xFLAG-mzt1 cells showed decreased levels of Alp6 in
cell lysates, with a corresponding decrease in coimmunopurifi-
cation of g-TuSC proteins with Mto1[bonsai] (Figures S4J and
S4K). Overall, these in vivo results are consistent with our
in vitro results indicating a role for Mzt1 in stabilization of
Alp6. While the absence of Mzt1 appears to lead to different
ultimate fates for Alp6 in vitro versus in vivo (i.e., aggregation
versus probable degradation, respectively), this may be a sec-
ondary consequence of different Alp6 concentrations and/or
environmental conditions in vitro versus in vivo.
Mzt1 Is a Dimer in Solution
Mzt1 proteins from S. pombe, C. albicans and human have been
described to form higher-order oligomers in vitro, ranging from
trimers/tetramers to dodecamers, and this oligomerization is
an important feature in several models for Mzt1 function within
multimeric g-TuCs [10, 11, 13, 36]. Given our finding that
S. pombe Mzt1 has a primary role in maintaining Alp6 stability
within the MGM holocomplex, we analyzed the oligomerization
state of purified Mzt1 by size-exclusion chromatography with
multi-angle light scattering (SEC-MALS; Figures S4L and S4M).
While the position of Mzt1 elution suggested a mass of
40 kDa relative to protein standards, SEC-MALS indicated a
molecular mass of 16.9 kDa. Because S. pombe Mzt1 has a
theoretical monomericmolecular mass of8.8 kDa, this strongly
suggests that it is a dimer in solution. While it is possible that
Mzt1 has different oligomerization states in different organisms,
we note that previous analyses were based on protein expres-
sion in E. coli. We expressed Mzt1 in insect cells, which may
aid proper folding, and we determined molecular mass by
SEC-MALS rather than by comparison with elution of protein
standards. As Mzt1 is expected to be almost exclusively a-heli-
cal [36], it may have an elongated structure, resulting in a dispro-
portionally large Stokes’ radius and thus higher apparent mass in2204 Current Biology 29, 2199–2207, July 8, 2019conventional SEC. The biological significance of Mzt1 dimeriza-
tion remains to be investigated.
Concluding Remarks
The reconstituted S. pombeMGM holocomplex is a robust MT
nucleator in vitro: it is active at (estimated) nanomolar/
subnanomolar concentrations, and it can efficiently nucleate
MTs from mammalian tubulin. MGM may thus be a useful
tool for further in vitro studies on how nucleators and MT-as-
sociated proteins cooperate to regulate MT assembly and
dynamics [4, 7].
Importantly, two of our key findings concerning the role of
S. pombeMzt1 in MT nucleation differ significantly from recent
in vitro work involving the equivalent proteins (‘‘Ca’’ proteins) in
the dimorphic yeast C. albicans [10]. First, CaMzt1 has been
described as promoting oligomerization of Cag-TuSC [10].
However, we find that in S. pombe, Mzt1 prevents aggregation
of g-TuSC, and this is likely a direct consequence of Mzt1’s
ability to directly prevent aggregation of Alp6 (Figure 4G). Sec-
ond, CaMzt1 interacts not only with CaSpc98 (homolog of
S. pombe Alp6 and human GCP3; see Figure S1A) but also
directly with the CM1 protein CaSpc110, effectively ‘‘bridging’’
CaSpc98 and CaSpc110, which also interact independently
[10]. The three-way interaction of CaMzt1, CaSpc98, and
CaSpc110 has been suggested to drive Cag-TuSC:CaSpc110
oligomeric rings into a more compact form, leading to a
3-fold increase in MT nucleation in the presence versus the
absence of CaMzt1 [10]. By contrast, while we identified inter-
actions between S. pombe Mzt1 and Alp6, and between Alp6
and the CM1 protein Mto1[bonsai], we did not find a direct
interaction between Mzt1 and Mto1[bonsai] (Figure 4F).
Accordingly, our collective results suggest a different view for
the role of Mzt1 in MT nucleation in S. pombe relative to
C. albicans, namely that inS. pombe, Mzt1 functions to stabilize
Alp6 within the g-TuSC in the face of Mto1-induced conforma-
tional changes that may be necessary to generate a functional
MT nucleator.
The idea that Mzt1 could have distinct mechanistic roles in
different types of MT nucleation complexes may find further
support from recent analyses in metazoans. In human,
MOZART1 has been shown to bind to the N terminus of not
only GCP3 (homolog of Alp6, Spc98, and CaSpc98) but also
the related g-TuRC proteins GCP5 (homolog of S. pombe
Mod21) and GCP6 (homolog of S. pombe Alp16) and also
possibly GCP2 (homolog of Alp4, Spc97, and CaSpc97)
[10, 13] (Figure S1A). MOZART1 RNAi in human cells in culture
profoundly impairs g-TuRC function, although experiments in
different cell types have produced conflicting results as to
the specific mechanism involved [8, 10, 13]. In Drosophila,
Mzt1 interacts only weakly with the GCP3 homolog Grip91,
more strongly with the GCP5 homolog Grip128, and not at
all with the GCP6 homolog Grip163 [37]. However, in
Drosophila, Mzt1 is non-essential for viability of the organism
and appears to play a critical role only in sperm development
[37]. One potential unifying concept from these diverse
systems, including the yeasts, is that there may be multiple
ways of multimerizing g-TuSCs to make g-TuRCs or
g-TuRC-like ring structures in different systems and thus
also multiple ways to achieve the conformational changes
necessary to generate an active MT nucleator. These in turn
may dictate the specific mechanistic role(s) of Mzt1, as well
as its general functional importance.STAR+METHODS
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Mouse monoclonal anti-g-tubulin antibody,
clone GTU-88
Sigma-Aldrich Cat# T6557; RRID:AB_477584
Sheep anti-Mto1 (serum) Homemade lab stock N/A
Sheep anti-Mto2 (serum) Homemade lab stock N/A
Sheep anti-GFP, affinity-purified Homemade lab stock N/A
Mouse monoclonal Anti-FLAG M2 antibody Sigma-Aldrich Cat# F1804; RRID:AB_262044
Mouse monoclonal anti-Goat/Sheep IgG antibody,
clone GT-34
Sigma-Aldrich Cat# G2904; RRID:AB_259856
IRDye 800CW Donkey anti-Mouse IgG (H+L) LI-COR Cat# 926-32212; RRID:AB_621847
Bacterial and Virus Strains
Escherichia coli DH10 EMBacY Imre Berger Lab [38]; N/A
Escherichia coli BL21-CodonPlus (DE3)-RIL Agilent Cat# 230245
Chemicals, Peptides, and Recombinant Proteins
4,6-diamidino-2-phenylindole, dihydrochloride (DAPI) Thermo Fisher Scientific Cat# D1306
Tubulin (porcine) > 99% Cytoskeleton, Inc. Cat# T240
Rhodamine-labeled porcine tubulin Cytoskeleton, Inc. Cat# TL590M
Chymostatin Melford Cat# C1104
Leupeptin hydrochloride > 90% Apollo Scientific Cat# BIMI2442
Aprotinin Apollo Scientific Cat# BIMI2132
Antipain dihydrochloride Apollo Scientific Cat# BIA0201
Pepstatin A Apollo Scientific Cat# BIMI2205
E-64 Apollo Scientific Cat# BIMI2157
Amylose resin New England Biolabs Cat# E8021L
Glutathione-agarose resin Sigma-Aldrich Cat# G4510
Strep-Tactin Sepharose resin IBA GmBH Cat# 2-1201-010
Fractogel EMD Chelate Merck Cat# 1.10338.0010
X-tremeGENE HP DNA Transfection Reagent Roche Cat# 6366244001
GIBCO Express Five SFM media Thermo Fisher Scientific Cat# 10486-025
Sf-900 II SFM Thermo Fisher Scientific Cat# 10902-096
L-Glutamine 200mM Thermo Fisher Scientific Cat# 25030024
Cre recombinase New England Biolabs Cat# M0298
Dextran sulfate sodium salt Sigma-Aldrich Cat# 31404
SYPRO Ruby gel stain Lonza Cat# LZ50562
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
hydrochloride (EDC)
Thermo Fisher Scientific Cat# 22980
sulfosuccinimidyl 4,4’-azipentanoate (Sulfo-NHS-Diazirine)
(Sulfo-SDA)
Thermo Fisher Scientific Cat# 26173
N-hydroxysulfosuccinimide (Sulfo-NHS) Thermo Fisher Scientific Cat# 24525
Ammonium bicarbonate Sigma-Aldrich Cat# 09830
1,4-Dithiothreitol (DTT) Sigma-Aldrich Cat# 10197777001
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Iodoacetamide Sigma-Aldrich Cat# I1149
Pierce Trypsin protease Thermo Fisher Scientific Cat# 90057
RunBlue SDS Running Buffer Expedeon Cat# NXB50500
Protein G Dynabeads Thermo Fisher Scientific Cat# 10003D
Bacto Yeast Extract BD Biosciences Cat# 212750
Bacto Agar BD Biosciences Cat# 214030
Critical Commercial Assays
Gateway LR Clonase II enzyme mix Thermo Fisher Scientific Cat# 11791-020
Gateway BP Clonase II enzyme mix Thermo Fisher Scientific Cat# 11789-020
Deposited Data
MS proteomics data deposited to ProteomeXchange
Consortium via PRIDE
This paper ProteomeXchange: PXD012624
Experimental Models: Cell Lines
Sf9 cells Thermo Fisher Scientific Cat# 11496015
High Five (BTI-TN-5B1-4) cells Thermo Fisher Scientific Cat# B85502
Experimental Models: Organisms/Strains
Schizosaccharomyces pombe This paper NCBI:txid4896
h- ade6-M210 leu1-32 ura4-D18 This paper KS516
h- hphMX6:nmt81:3xFLAG-mzt1 ade6-M210 leu1-32 ura4-D18 This paper KS7623
h- mto1(131-549)-mEcitrine:kanMX6 natMX6:Z:adh15:mCherry-
Atb2 ade6-M210 ura4-D18 leu1-32
This paper KS10055
h- hphMX6:nmt81:3xFLAG-mzt1 mto1(131-549)-mEcitrine:kanMX6
natMX6:Z:adh15:mCherry-Atb2 ade6-M210 ura4-D18 leu1-32
This paper KS10059
Oligonucleotides
Primers for PCR, see Table S1 This paper N/A
Recombinant DNA
pFL vector Imre Berger Lab [38]; pKS1219
pUCDM vector Imre Berger Lab [39]; pKS1251
pMK-RQ XhoI_L21_Gtb1_NheI (to generate untagged Gtb1) GeneArt (this paper) pKS1815
pMA BamHI_Alp4_TAA_PstI (to generate untagged Alp4) GeneArt (this paper) pKS1807
pMA BamHI_L21_Alp6_TAA_PstI (to generate untagged Alp6) GeneArt (this paper) pKS1812
pMK-RQ KasI_MBP_His_PstI (to generate C-terminal
MBP-6xHis tags)
GeneArt (this paper) pKS1811
pMK-RQ BamHI_Alp4_KasI (to generate tagged Alp4) GeneArt (this paper) pKS1814
pMK-RQ BamHI_L21_Alp6_KasI (to generate tagged Alp6) GeneArt (this paper) pKS1810
pMA-T Mzt1 (insect cells) (to generate Mzt1 codon-optimized
for insect cell expression)
GeneArt (this paper) pKS1813
pFL_Alp6-MBP_Gtb1 This paper pKS1791
pUCDM_Alp4_Gtb1 This paper pKS1788
g-TuSC Alp6-MBP This paper pKS1794
pFL_Alp4_Gtb1 This paper pKS1804
pFL_Mzt1-6xHis This paper pKS1801
pFL_6xHis-Mto1/2[bonsai] This paper pKS1225
pFL_GST-Mto1bonsai This paper pKS1548
pFL_6xHis-Mto2 This paper pKS1258
pUCDM_Alp6_Gtb1 This paper pKS1785
g-TuSC Untagged This paper pKS1805
pFL_Alp4-MBP This paper pKS1795
pFL_Alp6-MBP This paper pKS1796
pFL_Strep-Mto1/2[bonsai] This paper pKS1799
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p0GWA vector Didier Busso Lab [40]; pKS537
pGGWA vector Didier Busso Lab [40]; pKS538
pMA-T Mzt1_bac (to generate Mzt1 codon-optimized for
bacterial expression)
GeneArt (this paper) pKS1809
p0GWA Mzt1_6xHis This paper pKS1821
pGGWA GST_Mzt1_6xHis This paper pKS1822
pFA6a-hphMX6-P81nmt1-3FLAG Addgene [41]; RRID:Addgene_19350; pKS1284
pFA6a-mEcitrine-KanMX6 Addgene [42]; RRID:Addgene_105150; pKS1330
Software and Algorithms
ImageJ (Fiji) NIH RRID:SCR_002285
GraphPad Prism 7 software GraphPad RRID:SCR_002798
S. pombe database (released in August, 2013) PomBase RRID:SCR_006586
Image Studio Lite LI-COR RRID:SCR_013715
Image Lab Bio-Rad RRID:SCR_014210
Other
Bolt 4-12% Bis-Tris Gel Thermo Fisher Scientific Cat# NW04125BOX; Cat# NW04127BOX;
Cat# NW04122BOX; Cat# NW04120BOX
RunBlue 4-20% Teo-Tricine SDS Gels Expedeon Cat# NXG42012
A¨KTA chromatography system GE Healthcare N/A
A¨KTAmicro chromatography system GE Healthcare N/A
Viscotek SEC-MALS 20 detector Malvern Instruments N/A
Viscotek RI detector VE3580 Malvern Instruments N/A
Amicon Ultra-4 Ultracel-3K centrifugal filter unit Millipore Cat# UFC800324
Amicon Ultra-15 Ultracel-3K centrifugal filter unit Millipore Cat# UFC900324
Half area 96 well plate Greiner Bio-One Inc. Cat# 675076
Coverslips 24x50 mm No. 1.5 VWR Cat# 631-0147
Gradient Master 107ip Biocomp Instruments N/A
SpectraMax M5 multi-mode microplate reader Molecular Devices N/A
Superose 6 10/300 GE Healthcare Cat# 17-5172-01
Superdex 75 10/300 GE Healthcare Cat# 17-5174-01
Beckman Coulter Optima MAX Ultracentrifuge Beckman Coulter N/A
ChemiDoc Imager Bio-Rad Cat# 17001401
Odyssey CLx fluorescence imager LI-COR N/A
Airyscan confocal microscope Zeiss LSM880
Freezer/mill LLC 6870 SPEX SamplePrep N/A
400 mesh copper grid with carbon film support TAAB Cat# C169/100
Filter paper, grade 1 Whatman Cat# 1001-090
JEM-1400 transmission electron microscope JEOL JEM-1400
OneView 4k x 4k CMOS detector Gatan N/ACONTACT FOR REAGENT AND RESOURCE SHARING
Further requests for reagents and resource sharing should be directed to and will be fulfilled by the Lead Contact, Prof. Kenneth
Sawin (ken.sawin@ed.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Bacterial strains
Escherichia coli strains DH5alpha, DH10 EMBacY [38] (kindly provided by Imre Berger, University of Bristol, UK) and BL21-
CodonPlus (DE3)-RIL (Agilent) were grown at 37Con LB agar plates or in LB liquidmediumwith shaking at 200 rpm. For experimentse3 Current Biology 29, 2199–2207.e1–e10, July 8, 2019
involving protein expression in BL21-CodonPlus (DE3)-RIL cells, cultures were grown at 18C prior to and during induction of
expression.
Insect cell lines
Spodoptera frugiperda Sf9 cells (Thermo Fisher Scientific) and Trichoplusia niBTI-TN-5B1-4 High Five cells (Thermo Fisher Scientific)
were maintained as both adherent and suspension cultures at 27C. Sf9 cells were grown in Sf-900 II SFM medium (Thermo Fisher
Scientific), and High Five cells were grown in Express Five SFM medium with supplemented L-glutamine (Thermo Fisher Scientific).
Adherent cultures were split 1:4 when confluent (every 2-3 days). Suspension cultures were shaken in flasks at 120 rpm and main-
tained at 23 106 cells/mL to ensure optimal growth conditions. High Five suspension cultures were supplemented with 25 mg/mL
dextran sulfate (Sigma-Aldrich) to prevent cell clumping.
Fission yeast strains
Fission yeast Schizosaccharomyces pombe cells were grown either in YE5S rich medium, using Bacto Yeast Extract (BD Biosci-
ences) or in EMMG (also known as PMG) minimal medium [43]. Cells were grown on plates containing 2% Bacto Agar (BD Biosci-
ences) or in liquid culture with shaking at 150-160 rpm, at either 25C or 32C, depending on requirements. Media supplements
(e.g., adenine, leucine, and uracil) were used at 175 mg/L. For experiments shown in Figure S4, cells were grown in EMMGmedium
at 32C.
METHOD DETAILS
Plasmids for baculovirus expression
Recombinant proteins were produced using the MultiBac baculovirus system, and plasmids were constructed using MultiBac trans-
fer vectors pFL and pUCDM, kindly provided by Imre Berger [38, 39]. Coding sequences for Alp4 (pKS1807, pKS1814), Alp6
(pKS1810, pKS1812), Gtb1 (pKS1815), Mzt1 (pKS1813), and the maltose-binding protein (MBP) tag (pKS1811) were codon-opti-
mized for insect-cell expression and synthesized by GeneArt (Thermo Fisher Scientific). In order to construct a modular expression
system, coding sequences were flanked by specific restriction sites to allow subcloning into pFL and pUCDM, each of which contain
two separate multicloning sites (MCSs), each under control of a different baculovirus promoter [38, 39].
A plasmid for expression of g-TuSCAlp6-MBP, pKS1794, was constructed by a multistep process, as follows. Alp6 plus MBP coding
sequences (from pKS1810 and pKS1811, respectively) were subcloned into BamHI/PstI sites within MCS2 of pFL, to generate
pKS1796, which allows expression of Alp6-MBP under control of the polh promoter. The Gtb1 coding sequence from pKS1815
was then subcloned into XhoI/NheI sites within MCS1, to generate pKS1791, which further allows expression of Gtb1 under control
of the p10 promoter. In parallel, the Alp4 (untagged) coding sequence from pKS1807 and the Gtb1 coding sequence from pKS1815
were subcloned into pUCDM, using BamHI/PstI sites within MCS2 and XhoI/NheI sites within MCS1, respectively. This generated
pKS1788, which allows expression of untagged Alp4 and Gtb1 under control of polh and p10 promoters, respectively. pKS1791
and pKS1788 were then combined by site-specific recombination, using Cre recombinase (New England Biolabs), to generate
pKS1794.
A plasmid for expression of untagged g-TuSC, pKS1805, was constructed by similar methods. Alp4 and Gtb1 coding sequences
(from pKS1807 and pKS1815, respectively) were subcloned stepwise as above into pFL, to generate pKS1804, which allows expres-
sion of untagged Alp4 and Gtb1 under control of polh and p10 promoters, respectively. In parallel, Alp6 (untagged) and Gtb1 coding
sequences (from pKS1812 and pKS1815, respectively) were subcloned stepwise as above into pUCDM, to generate pKS1785, which
allows expression of untagged Alp6 and Gtb1 under control of polh and p10 promoters, respectively. pKS1804 and pKS1785 were
then combined by site-specific recombination, using Cre recombinase, to generate pKS1805.
A plasmid for expression of Alp4-MBP, pKS1795, was constructed by subcloning Alp4 plus MBP coding sequences (from
pKS1814 and pKS1811, respectively) into BamHI/PstI sites within MCS2 of pFL, allowing expression of Alp4-MBP under control
of the polh promoter.
A plasmid for expression of Mzt1-6xHis, pKS1801, was constructed as follows. To introduce a hexahistidine (6xHis) tag on
the C terminus of Mzt1, the Mzt1 coding sequence was amplified from pKS1813 by PCR, using primers OKS2838 and OKS2839.
The resulting product was cloned into BamHI/PstI sites within MCS2 of pFL, allowing expression of Mzt1-6xHis under control
of the polh promoter.
A plasmid for expression of 6xHis-Mto1/2[bonsai], pKS1225, was constructed by stepwise cloning of a PCR product for 6xHis-
Mto1[bonsai] (comprising amino acids 131-549 of Mto1) into NcoI/NsiI sites within MCS1 of pFL and a PCR product for Mto2 into
BamHI/SalI sites within MCS2, allowing expression of 6xHis-Mto1[bonsai] and Mto2 under control of the p10 and polh promoters,
respectively. The 6xHis-Mto1[bonsai] coding sequence was amplified from pKS272 (lab stock), using primers OKS2182 and
OKS2184. The Mto2 coding sequence was amplified from pKS415 (lab stock), using primers OKS2185 and OKS2186. The Mto2
PCR product contained a BclI site (compatible with BamHI) rather than a BamHI site, because of internal BamHI sites within the
Mto2 coding sequence. A similar approach was used to construct a separate plasmid for single expression of 6xHis-Mto2,
pKS1258. The Mto2 coding sequence was amplified from pKS415, using primers OKS2320 and OKS2186, and the PCR product
was cloned into BamHI/SalI sites within MCS2 of pFL, allowing expression of 6xHis-Mto2 under control of the polh promoter.Current Biology 29, 2199–2207.e1–e10, July 8, 2019 e4
A plasmid for expression of GST-Mto1[bonsai], pKS1548, was constructed by subcloning the GST coding sequence into XmaI/
XhoI sites upstream of (and in frame with) the 6xHis-Mto1[bonsai] sequence that had already been cloned into MCS1 of pFL as
described above (i.e., without Mto2).
A plasmid for expression of Strep-Mto1/2[bonsai], pKS1799, was constructed by inserting a Twin-Strep-tag sequence on the N
terminus of Mto1[bonsai] via sequential PCR using the forward primers OKS2884 and OKS2883 and reverse primer OKS2978. For
simplicity, we refer to this as a Strep tag. The Strep-Mto1[bonsai] PCR product was cloned into XhoI/SphI sites within MCS1 of pFL,
allowing expression of Strep-Mto1[bonsai] under control of the p10 promoter. Mto2 was cloned into MCS2, as described above.
Bacmid generation
Bacmids were generated by Tn7-dependent transposition of the pFL-based and pFL/pUCDM/recombination-based plasmids
described above into DH10 EMBacY E. coli (containing the EMBacY baculovirus genome). Transformed cells were plated on agar
plates containing 50mg/mL kanamycin, 10mg/mL tetracycline, 7 mg/mL gentamycin, 0.2 mM IPTG and 200 mg/mL 5-bromo-3-
indolyl-beta-galactoside (Bluo-Gal) and incubated at 37C for 48 hours until blue/white colonies were formed. ‘Positive’ white
colonies (indicating integration) were identified, and single colonies were inoculated into 5 mL of LB containing 50mg/mL kanamycin,
10 mg/mL tetracycline and 7 mg/mL gentamycin and incubated overnight at 37Cwith shaking at 200 rpm. Recombinant bacmid DNA
was isolated for insect cell transfection.
Protein expression in insect cells
For baculovirus production, Sf9 cells were used, and for protein expression, High Five cells were used. For the initial production of
virus (V0), Sf9 cells were infected with EMBacY bacmid containing the gene(s) of interest. First, bacmid DNA was isolated by alkaline
lysis followed by precipitation. DNA was then resuspended in 40 mL of ddH2O and combined with 400 mL Sf-900 II SFM and 20 mL
X-tremeGENE HP DNA transfection reagent (Roche) and incubated for 30 min at room temperature. 100 mL of this mixture was then
added to each of four wells seededwith 0.63 106 Sf9 cells in a 6-well tissue culture plate, followed by incubation at 27C. After 48-60
hours, V0 was harvested by collecting the supernatant and filtering through a 0.45 mm syringe filter.
Amplification of viruses (V1 and V2) was performed as previously described [44]. Briefly, Sf9 cells were grown to 2 3 10
6 cells/mL
and then infected with V0 or V1 at a 1:10 (v/v) ratio relative to cell-culture medium. After 48 hours, V1 and V2 were collected by gentle
centrifugation of the culture at 500 x g (Heraeus Megafuge) for 10 min, followed by recovery of the supernatant, which was then
filtered through a 0.45 mm syringe filter. The amount of each virus used was optimized for protein expression. V0 and V1 were stored
at 4C. For coexpression of multiprotein complexes, High Five cells were grown to 2 3 106 cells/mL prior to infection with V2 bacu-
lovirus. V2 baculovirus was used at an equal volume for each protein, at a V2-to-High Five-culture ratio of 1:80 (v/v). YFP fluorescence
wasmonitored as an indication of protein expression, and cells were harvested at peak fluorescence (48-72 hours post-infection). To
harvest, cells were centrifuged at 1000 x g for 15 min, and cell pellets were washed with phosphate-buffered saline (PBS), repelleted
and snap-frozen in liquid nitrogen for storage at 80C.
For expression of g-TuSCAlp6-MBP, g-TuSCAlp6-MBP:Mzt1 and MGM holocomplex, cells were coinfected with equal volumes of V2
for g-TuSCAlp6-MBP, Mto1/2[bonsai] andMzt1 viruses, together with an equal volume of V2 virus for expression of Alp4 and Gtb1. This
additional virus was used to ensure that expression of untagged proteins was in excess (i.e., not limiting). This was confirmed from
western blot analyses of unbound proteins after overnight binding to beads for affinity purification.
Protein purification and pulldown assays
Purification of g-TuSCAlp6-MBP, g-TuSCAlp6-MBP:Mzt1 and theMGM holocomplex was achieved via affinity chromatography using the
MBP tag on Alp6. Briefly, insect cell pellets were resuspended and lysed in ten volumes of cold HB100 buffer (40 mM K-HEPES,
100 mM KCl, 1 mM EGTA, 1 mMMgCl2, 0.1 mM GTP, 1 mM DTT pH7.5) with 1 mM PMSF and 10 mg/mL each of CLAAPE protease
inhibitors (chymostatin, leupeptin, aprotinin, antipain, pepstatin, E-64). Lysates were sonicated three times for 15 s using a tip son-
icator, with a 5-min interval on ice between sonications. Sonicated lysates were then clarified by centrifugation, first at 4000 x g
(Megafuge, Thermo Scientific Heraeus) for 30 min at 4C, and then at 90,000 rpm for 10 min at 4C (Optima MAX Ultracentrifuge;
Beckman Coulter). Clarified cell lysates were then incubated with amylose resin (New England Biolabs) overnight at 4C on a tube
roller. On the following day, beads with bound proteins were washed sequentially with a minimum of 40 column volumes of
HB100 buffer and eluted with 50 mM maltose in HB100 at 4C. Purity of samples were analyzed by SDS-PAGE and Coomassie
Blue staining. The MBP tag was generally not removed because, due to the multiple copies of Alp6 in the multicopy protein com-
plexes, efficient elution of the complexes would require essentially 100% cleavage of the tag. In addition, as described further below,
complexes were found to be similarly functional both with and without removal of the tag.
Mzt1 was purified via a 6xHis tag on the Mzt1 C terminus. Clarified cell lysates were loaded on a Ni2+-charged 1 mL HiTrap
IMAC column (GE Healthcare) and eluted using a 5%–50% gradient with Buffer A = 100 mM Tris, 150 mM NaCl pH7.5 and Buffer
B = 100 mM Tris, 150 mM NaCl, 1 M imidazole pH 7.5. Fractions corresponding to the protein peak were collected, concentrated
on an Amicon Ultra-4 or Ultra-15 centrifugal filter unit (3 kDa cut-off; Millipore) and loaded onto a Superdex 75 10/300 column
attached to an A¨KTA chromatography system (GE Healthcare). The column buffer was 100 mM Tris, 150 mM NaCl pH 7.5. Protein
purity was confirmed by SDS-PAGE and Coomassie Blue staining. For the analysis of Mzt1 shown in Figure S4H, fractions were run
on a RunBlue 4%–20% Teo-Tricine SDS gel (Expedeon) with RunBlue SDS Running Buffer (Expedeon). On this gel system, Mzt1
migrates with a slightly lower apparent molecular weight compared to the gel systems used in other figures.e5 Current Biology 29, 2199–2207.e1–e10, July 8, 2019
Mto1/2[bonsai] was purified via a 6xHis tag on the N terminus of Mto1[bonsai]. Clarified cell lysates were precipitated with ammo-
nium sulfate at 20%saturation by incubatingwith an appropriate amount of ammonium sulfate (added as solid) for 2 hours at 4Con a
tube roller. The precipitate was then centrifuged at 25,000 rpm for 20 min at 4C (Beckman Coulter Avanti J-25), and pellets were
resuspended in HB100 buffer equal to the initial volume of clarified cell lysate. This resuspension was then incubated with
Ni2+-charged Fractogel (Merck) overnight at 4C on a tube roller. On the following day, beads with bound proteins were washed
sequentially with at least 40 column volumes of HB100 buffer and eluted with 300 mM imidazole in HB100. Protein fractions were
then concentrated by centrifugal filtration as above and loaded onto a Superose 6 10/300 column (GE Healthcare) with HB100 as
column buffer. Fractions were analyzed by SDS-PAGE, and protein purity confirmed by Coomassie Blue staining.
Assays for protein copurification with GST-Mto1[bonsai] were performed by first coinfecting High Five cells with equal volumes of
V2 virus for GST-Mto1[bonsai], Mto2, and g-TuSC (untagged), with and without V2 virus for Mzt1. Cell pellets were lysed as above,
and clarified cell lysates were incubated with glutathione agarose (Sigma-Aldrich) overnight at 4C on a tube roller. The next day,
agarose beads with bound proteins were washed with a minimum of 40 column volumes of HB100 buffer, and proteins were eluted
from the beads by heating at 95C in Laemmli sample buffer.
Assays for protein copurification with Strep-Mto1/2[bonsai] were performed similar to GST-Mto1[bonsai] coexpression, by coin-
fecting High Five cells with equal volumes of V2 virus for Strep-Mto1/2[bonsai] and g-TuSC (untagged), with and without V2 virus for
Mzt1. Clarified cell lysates were incubated with Strep-Tactin Sepharose beads (IBA) overnight at 4C on a tube roller. Bound proteins
were eluted from the beads by heating at 95C in Laemmli sample buffer and analyzed by SDS-PAGE and western blot to assay pro-
teins that copurified. In parallel experiments, proteins were released from the beads either by cleavage of the tag by rhinovirus 3C
protease or by elution with biotin in HB100 buffer.
To assay copurification of proteins with Mto1[bonsai], eluted samples were analyzed qualitatively by SDS-PAGE and Coomassie
Blue or SYPRO Ruby staining, and quantitatively by western blotting. Western blots were probed with homemade sheep anti-Mto1
(1:1000) [14], anti Mto2 (1:1000) [45], anti-Alp6 (1:1000) [16], anti-Alp4 (1:1000) [16], and anti-Mzt1 (1:1000; this study) antisera, fol-
lowed by unlabelled GT-34 mouse monoclonal anti-goat antibody (1:10000) (Sigma) and IRDye800CW donkey anti-mouse antibody
(1:5000). g-tubulin was detected usingmonoclonal anti-g-tubulin antibodyGTU-88 (1:5000) (Sigma) followed by anti-mouse antibody
(1:5000). Blots were imaged using an Odyssey fluorescence imager (LI-COR) and quantified using Image Studio Lite (LI-COR).
In all assays for copurification of untagged proteins with tagged proteins (i.e., after coexpression by coinfection), untagged proteins
were always expressed in excess, based on western blotting of unbound proteins after incubation of clarified cell lysates with gluta-
thione- or Strep-Tactin-agarose beads. Therefore, slight variations in ‘‘input’’ levels between different coinfection samples (e.g., Fig-
ure S4C) are not expected to affect results.
Except where explicitly indicated (see below), purification tags on all proteins (MBP or 6xHis tags) were not removed prior to use in
functional or analytical assays. The fact that MGM holocomplex is a potent nucleator in vitro suggests that neither the MBP tag on
Alp6 nor the 6xHis tags on Mto1[bonsai] or Mzt1 negatively affects their function. In this context, we also note that in assays for cop-
urification of g-TuSC proteins in the absence versus presence of Mzt1 (Figures 4 and S4), Alp6 was untagged.
For experiments in which tags were removed, MGMcomplexes were treated with 6xHis-tagged tobacco etch virus (TEV) protease,
to cleave the MBP-6xHis tag from the C terminus of the Alp6-MBP protein and the 6xHis-tags from the N- and C- terminus of Mto1
[bonsai] and Mzt1 proteins, respectively. TEV was added to MGM complex at a 1:85 (TEV:MGM) ratio (w/w) and incubated at 4C for
16 hours to ensure optimal cleavage of the tags. Removal of the cleaved MBP-His and His-tags, as well as (uncleaved) 6xHis TEV,
was achieved by binding to Ni2+-charged Fractogel EMDchelate (Merck) for 3 hours at 4C. SDS-PAGE andCoomassie stainingwere
used to confirm purity of untagged MGM complex (which had significantly decreased yield relative to tagged MGM). The untagged
MGM complex was then used for microtubule nucleation assays in the same way as tagged MGM complex (described below).
Density-gradient centrifugation
Glycerol density-gradient centrifugation was performed on affinity-purified proteins and complexes (described above). Isokinetic
glycerol gradients (2 mL, 10%–30% glycerol [w/v]) were prepared in HB100 buffer using a Gradient Master 107ip (Biocomp
Instruments) [23]. Gradients were loaded with 100 mL of proteins at 1 mg/mL. For analysis of the interaction between Mto1/2[bonsai]
and g -TuSC:Mzt1, 50 mL of each complex at 1 mg/mL was mixed and left to incubate at 4C for 15 min, and the total (100 mL) was
loaded onto the gradient. Gradients were centrifuged in a Beckman TLS-55 swinging bucket rotor at 55,000 rpm at 4C. Marker pro-
teins with known sedimentation values were analyzed in parallel, on separate gradients. 100 mL fractions were collected with a cut-off
pipette tip and analyzed by SDS-PAGE and SYPRO Ruby staining (Lonza). Glycerol density-gradient sedimentation for each sample
was performed twice: once at 45 min, and once at 80 min, with consistent results. A 2.5-hour centrifugation was also performed, but
the sedimentation peak was too close to the pellet fraction to be able to accurately determine S-values.
Quantification of SYPRO Ruby staining was performed using a ChemiDoc Imager and Image Lab software (Bio-Rad).
Size-exclusion chromatography and SEC-MALS
Size-exclusion chromatography analysis of g-TuSCAlp6-MBP, g-TuSCAlp6-MBP:Mzt1, Alp6-MBP and Alp-6MBP:Mzt1 was performed
on an A¨KTA chromatography system (GE Healthcare) using a Superose 6 10/300 column with HB100 as column buffer. 500 mL of
protein was loaded on the column, with a flow rate of 0.5 mL/min, and absorbance at 280nm was recorded for one column volume.
Fractions were collected in 250 mL volumes and analyzed by SDS-PAGE and Coomassie Blue staining.Current Biology 29, 2199–2207.e1–e10, July 8, 2019 e6
To determine the molecular mass of Mzt1 in solution by size-exclusion chromatography with multi-angle light scattering (SEC-
MALS), an A¨KTAmicro chromatography system (GE Healthcare) coupled to UV, static light scattering and refractive index detection
(Viscotek SEC-MALS 20 and Viscotek RI Detector:VE3580; Malvern Instruments) was used. 100 mL of 1.98 mg/mLMzt1 was run on a
Superdex-75 10/300 GL size-exclusion column (GE Healthcare) pre-equilibrated in 100 mM Tris, 50mM NaCl, pH7.5 at 22C with a
flow rate of 0.5mL/min. Light scattering, refractive index (RI) and A(280nm) were analyzed by a homo-polymermodel (OmniSEC soft-
ware, v 5.1;Malvern Instruments) using the following parameters forMzt1: vA / vc at 280nm0.34 AU.mL/mg and vn / vc of 0.185mL/g.
In vitro microtubule nucleation assay
For bulk fluorescence-based microtubule polymerization assays, we used the fluorescence reporter 4’,6-diamidino-2-phenylindole
(DAPI) (Thermo Fisher Scientific) [30] and porcine brain tubulin (Cytoskeleton, Inc.). Tubulin stock was made at 10 mg/mL in GB
(80 mM K-PIPES, pH 6.9, 2 mM MgCl2, 0.5 mM EGTA, 1 mM GTP), and DAPI stock made at 10 mM DAPI in GB. Reactions were
set up on ice by mixing purified recombinant protein complexes (in a total volume of 5 mL) with 10 mL of tubulin stock and 35 mL
DAPI stock (final volume, 50 mL). Final assay composition was 80 mM K-PIPES, pH 6.9, 2 mM MgCl2, 0.5 mM EGTA, 1 mM GTP,
7 mM DAPI, 2 mg/mL porcine tubulin. Reactions were then transferred into a 96-well half area black microplate (Greiner Bio-One,
Inc.) and measured on a SpectraMax M5 multi-mode microplate reader (Molecular Devices) at 360 nm excitation and 450 nm emis-
sion at 37C. Readings were acquired every minute for two hours.
For fluorescence microscopy-based microtubule polymerization assays, we used a 1:10 mix of rhodamine-labeled porcine brain
tubulin (Cytoskeleton, Inc.) to unlabeled porcine brain tubulin. Mixed tubulin stock was made at a total concentration of 5 mg/mL in
GB. Reactions were set up bymixing 1 mL of purified recombinant protein complexes, 4 mL of mixed tubulin stock (final concentration
2 mg/mL) and 5 mL of GB, to a final reaction volume of 10 mL, and incubated at 37C. 1 mL aliquots were taken at 10-min intervals and
diluted 1:10 in prewarmed fixing solution (50% glycerol plus 0.1% glutaraldehyde, in GB without GTP). 2.5 mL of this reaction was
then spotted onto a glass slide, covered with a 24x50 mm coverslip (VWR), and randomly-selected fields were imaged with a 63x
oil-immersion objective on an LSM880 laser scanning microscope with Airyscan (Zeiss).
For both the DAPI microtubule polymerization assays (e.g., Figure 3A), the molar concentration of MGM holocomplex was esti-
mated based on the assumption that the MGM holocomplex forms a g-TuRC-like ring complex consisting of 6.5 g-TuSCs (account-
ing for 13 g-tubulins per turn, with a half g-TuSC overlap) [18]. Our previous work also indicated that within each actively-nucleating
punctum in vivo, there are 2 copies of Mto1[bonsai] and2 copies of Mto2 per g-TuSC [23], consistent with other work in budding
yeast [31]. Therefore, our estimate for the molar concentration of the MGM complex (derived from mg/mL) assumes 6.5 copies of
Alp6-MBP, 6.5 copies of Alp4, 13 copies of Gtb1, 13 copies of Mto1/2[bonsai] and 6.5-13 copies of Mzt1 (because Mzt1 is a very
small protein, its mass does not contribute significantly to the total mass of MGM).
Microscopy image analysis
ImageJ (Fiji; NIH) was used to process all raw microscopy images. Images shown are maximum projections of 10 Z sections with
0.2 mmstep-size. To quantifymicrotubule polymerization, the total fluorescence signals from all microtubules within an individual field
were summed and plotted for each time point, using GraphPad Prism.
Antibody production
Antibodies against S. pombeMzt1 were generated using GST-Mzt1-6xHis and Mzt1-6xHis fusion proteins expressed in E. coli. The
Mzt1 coding sequence was codon-optimized for E. coli expression and synthesized by GeneArt, as plasmid pKS1809. Expression
plasmids were generated by Gateway cloning (Thermo Fisher Scientific), using vectors p0GWA (for Mzt1-6xHis) or pGGWA (for GST-
Mzt1-6xHis), kindly provided by Didier Busso [40]. First, PCR was used to amplify the Mzt1 coding sequence with a C-terminal
rhinovirus 3C protease cleavage site and flanking attB1/2 sites (for Mzt1-6xHis; using primers OKS2876 and OKS2875) or with an
additional N-terminal TEV protease cleavage site (for GST-Mzt-6xHis; using primers OKS2874 and OKS2875). PCR products
were integrated into the Gateway donor vector pDONR201 using BP clonase (Thermo Fisher Scientific), and then transferred, using
LR clonase (Thermo Fisher Scientific), into p0GWA to generate the Mzt1-6xHis expression plasmid pKS1821, or into pGGWA to
generate the GST-Mzt1-6xHis expression plasmid pKS1822. Recombinant proteins were expressed in BL21-CodonPlus (DE3)-
RIL E.coli (Agilent) by induction with 1mM IPTG for 18 hours at 18C.
Recombinant proteins were purified from inclusion bodies via the 6xHis-tag, under denaturing conditions. Proteins were further
purified by SDS-PAGE, and the gel slice was lyophilized and ground to a fine powder prior to immunization. Antibodies raised against
GST-Mzt1-6xHis gave the best signal on western blots; crude anti-Mzt1 sheep serumproduced a single band of the expected size on
western blots, without the need for further affinity purification (e.g. Figure S2B), and no band was observed in negative controls.
Crosslinking mass spectrometry
For cross-linkingmass spectrometry, MGMholocomplex and Alp6-MBP:Mzt1 complex were cross-linked (independently) with either
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC)/N-hydroxysulfosuccinimide (Sulfo-NHS) or sulfosuccinimidyl
4,4’-azipentanoate (Sulfo-SDA) (Thermo Fisher Scientific). The MGM complex was incubated with EDC and Sulfo-NHS at a
1:2:4.4 (w/w/w) ratio for 90 min at 18C in 40 mM K-HEPES, 300 mM NaCl, 1 mMMgCl2 pH7.5. Alp6-MBP:Mzt1 complex was incu-
bated with either EDC/Sulfo-NHS at a 1:6:13.2 (w/w/w) ratio for 90 min at 18C, or with Sulfo-SDA at a 1:0.3 (w/w) ratio for 1 hour on
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(Bolt; Thermo Fisher Scientific), stained with Coomassie Blue at room temperature for 1 hour, and destained with 10% acetic
acid overnight. On the following day, gels were washed twice in MilliQ water for 30 min each. The higher molecular-weight bands
(> 250 kDa; for both complexes) and Alp6-MBP bands (for experiments involving Alp6-MBP:Mzt1) were excised with a clean scalpel
for further analysis.
Excised gel bandswere first destained by incubating with 50mMammonium bicarbonate (Sigma-Aldrich) and 100%acetonitrile at
a 1:1 ratio (v/v) for 1 hour at 37C with shaking. Proteins were then digested with trypsin, following previously established protocols
[46]. Briefly, proteins were first reduced with 10 mM DTT (Sigma-Aldrich) for 30 min at 37C in a shaker and alkylated with 55 mM
iodoacetamide (Sigma-Aldrich) for 20 min at room temperature, followed by trypsin digestion overnight at 37C (Thermo Fisher
Scientific).
Peptides from the MGM holocomplex were fractionated after digestion using SCX-Stage-Tips [47, 48]. In brief, peptide mixtures
were loaded on a SCX-Stage-Tip with loading buffer (0.5% v/v acetic acid, 20% v/v acetonitrile, 50 mM ammonium acetate). The
bound peptides were eluted into two fractions, with buffers containing 100mM ammonium acetate and 500mM ammonium acetate,
respectively. These peptide fractions were subsequently desalted using C18-StageTips [49] for LC-MS/MS analysis.
Peptides from the Alp6-MBP:Mzt1 complex were loaded onto StageTips for desalting and eluted in 80% acetonitrile in 0.1% TFA
prior to LC-MS/MS analysis.
For the MGM holocomplex, LC-MS/MS analysis was performed using Orbitrap Fusion Lumos (Thermo Fisher Scientific) with a
‘‘high/high’’ acquisition strategy. Peptide separation was carried out on an EASY-Spray column (50 cm 3 75 mm i.d., PepMap
C18, 2 mm particles, 100 A˚ pore size, Thermo Fisher Scientific). Mobile phase A consisted of water and 0.1% v/v formic acid. Mobile
phase B consisted of 80% v/v acetonitrile and 0.1% v/v formic acid. Peptides were loaded at a flow rate of 0.3 mL/min and eluted at
0.2 mL/min using a linear gradient from 2%mobile phase B to 40%mobile phase B over a period of 109 min (for MGM holocomplex
fractions) or 139min (for Alp6-MBP:Mzt1), followed by a linear increase from 40% to 95%mobile phase B over a period of 11min. The
eluted peptides were directly introduced into the mass spectrometer.
MS data were acquired in the data-dependent mode with 3 s acquisition cycle. Precursor spectrum was recorded in the Orbitrap
with a resolution of 120,000. The ions with a precursor charge state between 3+ and 8+ were isolated with a window size of 1.6 m/z
and fragmented using high-energy collision dissociation (HCD) with collision energy 30. The fragmentation spectra were recorded in
the Orbitrap with a resolution of 15,000. Dynamic exclusion was enabled with single repeat count and 60 s exclusion duration.
Themass spectrometric raw files were processed into peak lists usingMaxQuant (version 1.5.3.30) [50], and cross-linked peptides
were matched to spectra using Xi software (version 1.6.745) (https://github.com/Rappsilber-Laboratory/XiSearch). Protein se-
quences for searches were obtained from the S. pombe database (PomBase; August 2013 release; https://www.pombase.org)
[51], with added sequences for relevant tags (e.g., MBP tag on Alp6). Search parameters were: MS accuracy, 3 ppm; MS/MS accu-
racy, 10ppm; enzyme, trypsin; cross-linker, EDC; maxmissed cleavages, 4; missingmono-isotopic peaks, 2; fixedmodification, car-
bamidomethylation on cysteine; variable modifications, oxidation on methionine and phosphorylation on serine; fragments, b and y
ions with loss of H2O, NH3 and CH3SOH. FDR was estimated using XiFDR on 5% residue level [52].
Fission yeast strain construction
A fission yeast strain was constructed to express FLAG-taggedMzt1 at the endogenousmzt1 locus under the control of the thiamine-
repressible nmt81 promoter [53], because previous work showed that repression of nmt81-drivenmzt1 compromisesmzt1 function
in vivo [11]. We generated an nmt81:3xFLAG-Mzt1 strain by PCR-based gene tagging, as follows. The plasmid pFA6a-hphMX6-
P81nmt1-3FLAG (pKS1284; Addgene #19350 [41] was purchased from Addgene and amplified by PCR using oligonucleotides
OKS2671 (forward primer) and OKS2672 (reverse primer) and Phusion DNA polymerase (New England Biolabs). Purified PCR prod-
uct was used to transform strain KS516, followed by selection for stable-integrant hygromycin-resistant strains that showed normal
growth on EMMG (also known as PMG) minimal medium plates [43] lacking thiamine and poor or no growth on equivalent plates con-
taining 15 mM thiamine (Figure S4I). The resulting strain was named KS7623. Repression of 3xFLAG-Mzt1 expression in the presence
of thiamine was confirmed by anti-FLAG western blotting (Figure S4J). Because our anti-Mzt1 antibody used to detect recombinant
protein was not sufficiently sensitive to detect untagged Mzt1 in fission yeast, the expression level of non-repressed nmt81:3xFLAG-
Mzt1 relative to untagged Mzt1 (under control of the endogenousmzt1+ promoter) is not known. Themto1[bonsai]-mECitrine strain
was also constructed by PCR-based gene tagging, using template plasmid pFA6a-mEcitrine-KanMX6 (pKS1330; Addgene #105150)
[42] and oligonucleotides OKS2105 (forward primer) and OKS2116 (reverse primer). Purified PCR product was used to transform
strain KS516. The resulting strain, KS7462, which expresses Mto1[bonsai]-mECitrine under control of the endogenous mto1 pro-
moter at themto1 locus, was confirmed by colony PCR, microscopy and western blotting. Strains used for co-immunoprecipitation
experiments (i.e., strains KS10055 and KS10059) were derived from KS7623 and KS7462 by conventional genetic crosses [54].
Fission yeast coimmunoprecipitation
Mto1[bonsai] immunoprecipitation (IP) experiments from nmt81:3xFLAG-Mzt1 and control strains were performed using strains
KS10059 and KS10055, respectively. In text and figures, we refer to the control strain KS10055 as ‘‘wild-type.’’ Both strains were
grown in minimal EMMG medium with supplements to mid-log phase, harvested, washed with STOP buffer (10 mM EDTA,
50 mM NaF, 150 mM NaCl, 1 mM NaN3), resuspended in water and snap-frozen in liquid nitrogen. For mzt1 shut-off and control
experiment, 20 mM thiamine were added to the PMG medium for 16 hr. Cryogrinding of frozen cells was performed under liquid
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for 2 min, with beat rate = 10. 3.74 g of frozen cell powder was thawed for 20 min at 4C in 7.5 mL IP buffer (50 mM Tris-HCl pH 7.5,
50 mM NaF, 150 mM NaCl, 20 mM Sodium beta-glycerophosphate, 0.2% Triton X-100, 1 mM sodium orthovanadate, 1 mM EDTA,
10 mg/mL of each ‘CLAAPE’ protease inhibitors, 2 mM AEBSF, 2 mM PMSF). Cell lysate was then clarified by two cycles of centri-
fugation (4500 rpm; 15 min each cycle) at 4C, and the pellets were discarded. 164 mL of clarified cell lysate was mixed with equal
volume of Laemmli sample buffer (containing 1% beta-mercaptoethanol), heated to 95C for 3 min and kept as an ‘‘input’’ sample.
The remainder wasmixedwith 150 mL Protein GDynabeads slurry (Thermo Fisher Scientific; 10003D) that had been previously cross-
linked to homemade affinity-purified sheep anti-GFP antibody using dimethylpimelimidate [55], and the mixture incubated for 1 hr at
4Cwith gentle rotation, followed by washing three times with 500 mL IP buffer. Dynabeads were then incubated with Laemmli buffer
(without reducing agent), and heated to 95C for 3min. Eluates fromDynabeadswere then supplementedwith beta-mercaptoethanol
(0.5% v/v final). For SDS-PAGE, gel lanes were loaded with either 10 mL of input samples (corresponding to 5 mL of original clarified
lysate) or 10 mL of IP eluates (corresponding to 535 mL of original clarified lysate), except for Alp4 and Alp6, which used double the
amounts of each. Proteins were transferred to nitrocellulose bywet transfer. Western blots were stainedwith Ponceau S and scanned
prior to blocking in 5% milk in TBS-T (TBS buffer containing 0.1% TWEEN 20). Western blots were probed with homemade sheep
anti-Mto1 and anti-Mto2 antisera (both at 1:1,000), affinity-purified homemade sheep anti-Alp4 and anti-Alp6 antibodies (both at
1:100), mouse monoclonal anti-g-tubulin antibody (clone GTU-88, Sigma, T6557; at 1:5,000) or mouse monoclonal anti-FLAG anti-
body (clone M2, Sigma, F1804) in TBS-T plus 2% non-fat milk. Blots involving sheep primary antibodies were washed and then incu-
bated with mouse monoclonal anti-goat/sheep IgG antibody (clone GT-34, Sigma, G2904, at 1:10,000) to allow recognition by
labeled anti-mouse antibody. All blots were then washed and incubated with IRDye 800CW Donkey anti-Mouse IgG (LI-COR,
926-32212, at 1:5,000) in TBS-T plus 2% non-fat milk. Blots were imaged using an Odyssey CLx fluorescence imager (LI-COR)
and quantified using Image Studio Lite (LI-COR).
Electron microscopy
For negative stain EM, 4 ml of MGM holocomplex (including MBP tag on Alp6) at 170 mg/mL was added to freshly glow-discharged
copper grids (400 mesh, continuous carbon film; TAAB) and incubated for two minutes. Grids were blotted with filter paper (Grade 1;
Whatman) andwashed twice by touching with 15 mL buffer (40mMKHEPES, pH 7.5, 100mMKCl) and blotting after each wash. Grids
were then stained by touching a 15 mL droplet of 2% uranyl acetate solution two times, each time followed by immediate blotting, and
then touching a third time, followed by incubation for 2 min. Excess stain was then blotted away carefully, and grids were air-dried
and stored until imaged.
Electron microscopy was performed on a JEM-1400 transmission electron microscope (JEOL) operating at 80 kV, equipped with a
OneView 4k x 4k CMOS detector (Gatan Inc.) Images were recorded with a pixel size of 2.15 A˚, and a defocus of1 mm. images were
processed using ImageJ software.
Figure preparation
Images for figures were prepared using ImageJ (NIH), Photoshop (Adobe), Excel (Microsoft) and GraphPad Prism (GraphPad). Fig-
ures were compiled using Illustrator (Adobe)
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantification of tubulin polymerization by DAPI fluorescence
For tagged complexes, DAPI tubulin polymerization with: (i) 4.5 mg/mL MGM complex was performed 7 times; (ii) 0.45 mg/mL MGM
complex was performed once; (iii) 3.2 mg/mL g-TuSC:Mzt1 complex was performed 6 times; (iv) 0.32 mg/mL g-TuSC:Mzt1 was per-
formed once; (v) tubulin alone was performed 7 times; (vi) 3.8 mg/mL g-TuSC was performed once; (vii) 4.35 mg/mL g-TuSC:Mto1/2
[bonsai] was performed once; (viii) 0.86 mg/mLMto1/2[bonsai] was performed twice; and (ix) 2 mMpaclitaxel was performed twice. To
compare nucleation activity of tagged complexes with untagged complexes (which had much lower yield), DAPI tubulin polymeriza-
tion with: (i) 1.4 mg/mL tagged MGM complex; (ii) 1.4 mg/mL untagged MGM complex; and (iii) 1.7 mg/mL untagged g-TuSC:Mto1/2
[bonsai] was performed once.
Quantification of microtubules visualized by fluorescence microscopy
Total combined fluorescence signal for all microtubules within an image field was quantified for each random image taken, using
ImageJ software, and a total of ten measurements were plotted for each time point and condition, using GraphPad Prism software
(GraphPad). For experiments involving tagged complexes, microtubule polymerization for the MGM holocomplex with tubulin and
g-TuSCAlp6-MBP:Mzt1 complex with tubulin were performed four times, ‘‘tubulin alone’’ was performed twice, andMto1/2[bonsai com-
plex] with tubulin was performed once. For experiments involving untagged complexes, all experiments were performed once. Counts
of microtubule numbers were performed manually, using ten fields for tagged complexes and seven fields for untagged complexes.
Quantification of copurification by western blot and Coomassie Blue staining
Assays for copurification of Mto2 and g-TuSC with GST-Mto1[bonsai] and Strep-Mto1[bonsai] in the presence and absence of Mzt1
(Figures 4D and S4D) were quantified from western blots using Image Studio Lite software (LI-COR). Copurification assay with GST-
Mto1[bonsai] was performed once for all proteins analyzed. For copurification assayswith Strep-Mto1[bonsai], quantification of Alp6,e9 Current Biology 29, 2199–2207.e1–e10, July 8, 2019
Alp4 and Mto1[bonsai] was performed 4 times, quantification of Gtb1 was performed three times, and quantification of Mto2 was
performed once (because in some experiments the Mto2 signal was too high, out of linear range). Error bars show SEM. Coimmu-
noprecipitation experiments from fission yeast cell lysates were performed once.
Levels of Mto1[bonsai] relative to Alp4 or Alp6 (Figure 4B) after purification of the g-TuSCAlp6-MBP:Mto1/2[bonsai] complex in the
presence and absence of Mzt1 were quantified from Coomassie Blue staining, using Image Studio Lite software (LI-COR).
DATA AND SOFTWARE AVAILABILITY
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [56] partner
repository (https://www.ebi.ac.uk/pride/archive) with the dataset identifier ProteomeXchange: PXD012624.Current Biology 29, 2199–2207.e1–e10, July 8, 2019 e10
